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Background. Primary healthcare is the foundation of a country’s healthcare system. Without an efficient and cost-effective programme, the 
level of healthcare offered across all levels of health management is adversely affected. 
Objective. To analyse the effectiveness of the management of hypertension and diabetes mellitus (DM) among two distinct patient 
populations, one with significant cardiovascular risk factors and the other without.
Method. We performed a case control study of a high-risk group of patients presenting with chronic critical limb ischaemia (CLI) to the 
Divisions of Vascular Surgery at Charlotte Maxeke Johannesburg Academic Hospital and Chris Hani Baragwanath Academic Hospital, and 
a randomly selected group of ‘healthy’ community participants from Johannesburg’s South Western Townships (Soweto).
Results. We assessed 217 patients with CLI and 1 030 participants from the community. We assessed the number of patients who were not 
achieving their therapeuatic targets, among those known to be hypertensive (CLI: 44.7%; community: 59.9%) and diabetic (CLI: 83.5%; 
community: 66%). Undiagnosed diabetes affected 10.8% of patients with CLI and 11% of the community sample. 
Conclusion. Traditional vascular risk factors are managed poorly at both primary healthcare and at tertiary care levels. There is a need to 
identify factors that will address this issue. 
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Groups of black African 
descent living in South Africa 
(SA) are a population on the 
brink of an epidemiological 
health transition.[1] This 
population, which already bears a quadruple 
disease burden (HIV/AIDS; tuberculosis 
(TB); violence and injury; and poor maternal 
and child health)[2] now faces an increasing 
prevalence of degenerative and lifestyle 
disease. 
In 2008 the World Health Organization 
(WHO) emphasised that, especially in 
developing countries, effective primary 
healthcare (PHC) systems are essential to 
ensuring effective national healthcare. [3] This 
is the challenge facing our already strained 
public health system, which is already 
hampered by lack of infrastructure, dwindling 
numbers of medical professionals and 
inadequate resources. Is there evidence that 
we are managing chronic diseases adequately, 
or is there room for improvement?
Methods
We performed a case-controlled cross-
sectional study in the Divisions of 
Vascular Surgery at Charlotte Maxeke 
Johannesburg Academic Hospital and Chris 
Hani Baragwanath Academic Hospital, 
Johannesburg, SA. We recruited consecutive 
patients referred with chronic critical limb 
ischaemia (CLI), defined as ischemic rest 
pain present for >2 weeks; ulcers; or gangrene 
attributable to arterial occlusive disease.[4] 
Using an existing database, 1 030 parti-
cipants were drawn from randomly selected 
families of black African descent (Nguni 
and Sotho chiefdoms) from Johannesburg’s 
South Western Townships (Soweto)[5] and 
enrolled as a control group. Only adults were 
recruited, with siblings older than 16 years. 
The database was the product of the 
African Project on Genes in Hypertension 
(APOGH). The APOGH group consists of 
randomly selected participants representing 
a community – some with hypertension, 
some diabetic, some with no comorbidities 
– and follows these patients over years to
monitor disease progression and/or stability. 
Therefore, the APOGH group served as the 
ideal control group with which to compare a 
group of end-stage vascular disease patients. 
The study was conducted according to 
the principles of the Declaration of Helsinki. 
The University of the Witwatersrand’s 
Committee for Research on Human Subjects 
had previously approved the APGH protocol 
(approval number M02-04-72 and renewed 
as M07-04-69) as well as the current study 
(approval number M11-08-29). Participants 
gave written, informed consent.
A questionnaire obtained each participant’s 
medical history, use of medication and 
smoking habits. Height and weight were 
measured with participants in a standing 
position, and body mass index (BMI) 
was calculated. A fasting lipid profile 
(cholesterol:high density lipoprotein 
(HDL) cholesterol ratio) and glycosylated 
haemoglobin (HbA1c) were measured as 
biochemical indicators of the risk factors 
of hyperlipidaemia and diabetes mellitus 
(DM). 
Participants rested for 10 minutes in the 
supine position, after which 3 brachial blood 
pressure readings were obtained using an 
appropriately sized cuff. The mean of the 
3 readings was calculated and used as the 
patient’s blood pressure for that occasion. 
Hypertension was defined as either a systolic 
blood pressure >130 mmHg or diastolic 
blood pressure >80 mmHg in the CLI 
group, and either a systolic blood pressure 
>140 mmHg or diastolic blood pressure 
>90 mmHg in the community sample. Any 
patient taking anti-diabetic medication was 
considered to be diabetic. 
Statistical analysis and database manage-
ment were performed using SAS software 




A total of 217 patients with CLI were referred 
to our clinic, 78 (36%) from secondary level 
facilities and 139 (64%) from PHC clinics. 
Table 1 shows the demographic and clinical 
characteristics of the study samples. Patients 
with CLI were, on average, older, suffered 
from concomitant DM, were smokers and 
used alcohol more frequently. The majority 
were males. Of the community sample more 
were obese, with a higher mean BMI; their 
total cholesterol:HDL cholesterol ratio was 
higher. 
In the CLI group, 18 patients had suffered 
a previous ischemic coronary event and 9 
had suffered a cerebrovascular accident. No 
participants in the community sample gave a 
significant cardiovascular or cerebrovascular 
history.
Blood pressure 
Mean blood pressure was higher in the 
community sample, and both means were 
significantly higher than the recommended 
target blood pressure for their group. Table 2 
shows the comparison of blood pressure 
control between the two groups for their 
respective targets. A total of 154 CLI patients 
were hypertensive, of whom 139 were on 
treatment, 28 with monotherapy and 111 
with polytherapy. In the community sample 
268 participants were on treatment, 180 with 
monotherapy and 88 with polytherapy. 
Glycaemic control 
In both the community sample and the 
CLI group with DM, the mean HbA1c was 
significantly higher (>7.0%) (Table 2). In 
the CLI group, 97 patients were diagnosed 
with diabetes. In the control group, 103 
Table 1. Characteristics of participants
Community sample CLI group
Sample size, N 1 030 217
Males, % 36 71*
Age (years), mean±SD 43±18 62±12*
Height (cm), mean±SD 161±9 170±10*
Body mass index (kg/m2), mean±SD 28.5±7.3 26.3±5.9*
Waist circumference (cm), mean±SD 90.6±18.1 83.8±21*
Obese, % 39 18*
Hypertensive, % 42 62*
Receiving antihypertensives, % 23 62*
With diabetes mellitus, % 8 45*
Current smoker, % 16 51*
Previous smoker, % 24 68*
Regular alcohol, % 22 57*
BP (mmHg), systolic/diastolic, mean±SD 129±22/84±12 137±21*/80±12*
Glycated haemoglobin (%) 6.07±1.31 7.53±2.48*
Total/HDL cholesterol 3.49±1.24 4.04±1.69*
CLI = Critical lower limb ischemia, SD = standard deviation; HDL = high-density lipoprotein; BP = blood pressure.
*p<0.0001 v. community sample. 
RESEARCH
940  December 2013, Vol. 103, No. 12  SAMJ
participants were diagnosed with diabetes. 
Only 35 (34.0%) patients in the community 
sample and 16 (16.5%) in CLI group 
diagnosed with DM appeared to have 
achieved their HbA1c therapeutic target. Of 
the 927 patients in the community sample 
who did not have DM, 102 (11.0%) had 
an HbA1c >7.0%. Of the 120 patients with 
CLI who were not diagnosed with DM, 13 
(10.8%) had an HbA1c >7.0%. 
Serum lipids 
No patient in either sample was known to 
have hypercholesterolaemia (Table 2). All 
patients in the CLI group were on a statin 
as a component of their peripheral arterial 
disease management and their cholesterol 
levels were within accepted ranges. 
Smoking 
There was a high prevalence of smoking. 
The CLI group were more likely to smoke, 
but the amount smoked was low (Table 1). 
Indeed, for many the amount smoked was 
too irregular to calculate a daily average, 
many patients smoking <5 cigarettes/day. 
Both groups demonstrated a decrease in 
smoking from previous smoking, but current 
smoking levels remained significant.
Discussion 
We have studied risk factors for vascular 
disease and their management in patients 
with severe peripheral arterial disease, as 
well as in a randomly selected community 
sample. In SA, only 14 - 40% of patients 
achieve blood pressure control and 16 - 
50% of diabetics currently achieve glucose 
control. [6,7] Our data was in line with these 
studies for our group of patients at high 
risk for adverse cardiovascular events. 
Blood pressure and glycaemic control is 
poor in both groups but significantly worse 
in the CLI group. We have also shown 
that approximately 10% of the population 
have not had their DM diagnosed and may 
present to hospitals with complications of 
their disease, such as CLI.  Blood pressure 
and HbA1c values for the community 
sample are in keeping with other general 
SA community samples, as is their use of 
medication.[8,9] The community sample was 
significantly more overweight than the CLI 
group, in keeping with other SA studies.[9,10] 
In SA, clinical nurse practitioners are the 
main primary healthcare providers. From 
our study and several other community 
based studies in various provinces,[6,9-11] it 
appears that the current healthcare system is 
failing to serve the greater public. SA is not 
the only country in which nurse-led PHC 
has not succeeded. In 2000 the Japanese 
instituted a nurse-led PHC initiative 
called ‘Kenko-Nippon-21’ (Healthy Japan 
21).[12] An audit of its treatment effects in 
2004 showed that some outcomes for the 
population involved had worsened instead 
of improving. [8] In response, the Japanese 
began a new screening and intervention 
programme that identified individuals at 
risk, who were then referred to a doctor-
supervised counselling or intervention 
programme.[8] PHC should be doctor-led to 
improve quality of care.[13,14]
DM management can be significantly 
improved, even in resource-poor environ-
ments, through physician-patient contact, 
with up to 85% of patients achieving their 
glucose targets in diabetes-focused PHC 
clinics.[15] The initiation and ongoing use of 
insulin is a stumbling block in non-hospital 
clinics, and non-specialist nurses cannot 
be expected to commence or monitor this 
therapy.[16,17] On the other hand, specialist 
diabetic nurses working in PHC clinics do 
help patients achieve therapeutic targets.[17]
In Germany, disease-management 
programmes started in the 1990s and are 
run as secondary prevention programmes. 
Diagnosed patients are entered into 
specialist-led disease programmes in their 
area.[18] This system has been shown to be 
effective and economical over the long 
term.[19] Brazil has significantly improved its 
PHC system by developing a family-health 
programme, which runs clinics staffed by 
a doctor and nurse and linked to other 
clinics and regional medical centres through 
a comprehensive health-management 
information system.[20] In situations where 
there are no doctors, nurse-led clinics 
have led to improvement in diabetic and 
hypertensive parameters, thanks to the 
information system and clear referral 
pathways to regional medical centers. While 
the values did not fall within recognised 
therapeutic targets, improvements did reach 
statistical significance.[21]
The SA Government’s Primary Healthcare 
Services Package was designed to create 
‘one-stop public healthcare’ with a view 
to decreasing the burden on hospitals.[22] 
It is  evident from our study, as well as 
other community studies, that this policy 
has failed. If SA is to decentralise PHC, 
Table 2. Vascular risk factors and their therapeutic targets
Community sample CLI group
Hypertension, n 504 154
Therapeutic target 140/90 130/80
 Blood pressure (mmHg), systolic/
diastolic, mean±SD
144±23/91±13 138.34±19/79.67±11
 SBP above therapeutic target, n (%) 302 (59.9) 97 (44.7)
On therapy, n 268 139
Monotherapy 180 28
Polytherapy 88 111
Diabetes,* n 103 97
HbA1c, mean±SD 8.84±2.78 9.36±2.52
 HbA1c above therapeutic target, n (%) 68 (66.0) 81 (83.5)
Oral therapy alone, n 76 59
Insulin/combined therapy, n 27 38
Serum lipids,† n 430 217
Triglycerides (mmol/L), mean±SD 1.16±0.66 1.36±0.65
LDL (mmol/L), mean±SD 2.65±0.90 2.18±0.97
HDL (mmol/L), mean±SD 1.41±0.45 1.10±0.46
 Total cholesterol/HDL ratio, mean±SD 3.49±1.17 4.04±1.69
HIV-positive, n Not measured 25
CD4+ count ≤350 cells/μl, mean±SD Not measured 15
 CD4+ count, >350 cells/μl, mean±SD Not measured 331.43±84.1
CLI = Critical limb ischemia; SD = standard deviation; SBP = systolic blood pressure; HbA1c = glycosylated haemoglobin;  
LDL = low-density lipoprotein; HDL = high-density lipoprotein.
*Therapeutic target: HbA1c <7.0%†Triglyceride <1.7 mmol/l, LDL <3.0 mmol/l, HDL >1.03 (males), >1.29 (females)
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polyclinics with specialist nurses in chronic diseases such as DM and 
hypertension should be created. 
Medical care in SA remains hospi centric. [1,23] Though there are 
initiatives in place to alleviate the burden on hospitals (such as the 
National Strategic Plan on HIV, sexually transmitted infections 
and TB 2012 - 2016, which was launched on 1 April 2012,[23] and 
the proposed National Health Insurance (NHI) scheme), it will 
be several years before they come to fruition. In the meantime, 
hospital doctors should take every opportunity to provide PHC, 
and must not assume that patients will automatically receive it 
outside their hospital. A patient who is admitted for an inguinal 
hernia repair who is hypertensive and diabetic should have their 
blood pressure and diabetic management carefully evaluated before 
discharge. Upon discharge, doctors must carefully consider whether 
PHC or short-term hospital out-patient follow-up is appropriate for 
that specific patient. Once their comorbidities are well-controlled 
patients can be managed peripherally, with clear channels and 
protocols of referral back to the specialist clinic should the need 
arise. Widespread specialist nurse-led polyclinics could supplement 
the current PHC system by acting as an intermediate step to tertiary 
care. 
Conclusion
We have demonstrated poor cardiovascular risk-factor management 
in high-risk and low-risk patient cohorts in Gauteng, both at 
tertiary and primary care levels. Review of the SA literature 
highlights the defects of the PHC system. In improving PHC in SA, 
efforts should be made to learn from other PHC systems, such as 
the Japanese, German and Brazilian systems. The district clinical 
specialist teams that are planned for under the forthcoming NHI 
system may promote improved cardiovascular disease prevention 
and management. Until then, however, every patient encounter at 
any level of care should be considered an opportunity to prevent or 
manage chronic illnesses. 
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